← Back to headlines
Cantor Fitzgerald Downgrades ADMA Biologics to Neutral
Cantor Fitzgerald has downgraded ADMA Biologics Inc. (ADMA) from an 'Overweight' rating to 'Neutral.' This change indicates a revised investment recommendation for the company's stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
9h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
11h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
19h ago